temoporfin has been researched along with singlet oxygen in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 11 (84.62) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kopelman, R; Yan, F | 1 |
Foster, TH; Mitra, S; Wang, KK | 1 |
Chen, K; Langer, K; Possemeyer, K; Preuss, A; Roeder, B; Wacker, M | 1 |
Chen, K; Hackbarth, S; Langer, K; Ludwig, C; Röder, B; Wacker, M | 1 |
Chen, K; Hackbarth, S; Langer, K; Preuss, A; Röder, B; Wacker, M | 1 |
Alberto, ME; Marino, T; Quartarolo, AD; Russo, N | 1 |
Barberi-Heyob, M; Boisseau, P; Couffin, AC; Creusat, G; Frochot, C; Moussaron, A; Navarro, FP; Texier, I; Thomann, JS; Vanderesse, R; Verhille, M | 1 |
Capobianco, JA; Forgione, P; Lamoureux, G; Naccache, R; Rodriguez, EM; Sanz-Rodriguez, F; Scheglmann, D; Yu, Q | 1 |
Béalle, G; Clément, O; Di Corato, R; Espinosa, A; Kolosnjaj-Tabi, J; Ménager, C; Silva, AK; Wilhelm, C | 1 |
Ehrenberg, B; Haupt, S; Lazar, I; Senge, MO; Weitman, H | 1 |
Banin, U; Ehrenberg, B; Timor, R; Waiskopf, N; Weitman, H | 1 |
Al Fartousi, M; Bourajjaj, M; de la Escosura, A; Hennink, WE; Holappa, LP; Lappalainen, JP; Liu, Y; Mäkinen, PI; Setaro, F; Torres, T; Trohopoulos, PN; van den Dikkenberg, JB; van Nostrum, CF; Wennink, JWH; Ylä-Herttuala, S | 1 |
Looft, A; Pfitzner, M; Preuß, A; Röder, B | 1 |
13 other study(ies) available for temoporfin and singlet oxygen
Article | Year |
---|---|
The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties.
Topics: Antineoplastic Agents; Hydrogen-Ion Concentration; Mesoporphyrins; Nanotechnology; Particle Size; Photochemotherapy; Photosensitizing Agents; Silicon Dioxide; Singlet Oxygen; Spectrum Analysis | 2003 |
Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.
Topics: Algorithms; Animals; Computer Simulation; Disease Models, Animal; Mesoporphyrins; Mice; Models, Biological; Neoplasms; Photochemotherapy; Photosensitizing Agents; Radiation Dosage; Singlet Oxygen; Time Factors | 2008 |
Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
Topics: Adsorption; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Stability; Drug Storage; Ethanol; Freeze Drying; Humans; Hydrogen-Ion Concentration; Jurkat Cells; Leukemia, T-Cell; Mesoporphyrins; Microscopy, Electron, Scanning; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Porphyrins; Serum Albumin; Singlet Oxygen; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; Time Factors; Water | 2010 |
Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems.
Topics: Drug Carriers; Humans; Jurkat Cells; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Serum Albumin; Singlet Oxygen; Spectrophotometry, Ultraviolet | 2010 |
Photosensitizer loaded HSA nanoparticles II: in vitro investigations.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Endocytosis; Humans; Jurkat Cells; Kinetics; Mesoporphyrins; Microscopy, Confocal; Nanoparticles; Nanotechnology; Photosensitizing Agents; Porphyrins; Serum Albumin; Singlet Oxygen; Solubility; Technology, Pharmaceutical | 2011 |
Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory.
Topics: Humans; Mesoporphyrins; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Quantum Theory; Singlet Oxygen | 2013 |
Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy.
Topics: Cell Survival; Drug Carriers; Drug Compounding; Humans; Light; Lipids; MCF-7 Cells; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2014 |
Chemical modification of temoporfin--a second generation photosensitizer activated using upconverting nanoparticles for singlet oxygen generation.
Topics: Cell Survival; HeLa Cells; Humans; Infrared Rays; Mesoporphyrins; Nanoparticles; Photosensitizing Agents; Singlet Oxygen | 2014 |
Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes.
Topics: Ablation Techniques; Animals; Biological Transport; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Drug Liberation; Female; Humans; Hyperthermia, Induced; Liposomes; Magnets; Mesoporphyrins; Mice; Models, Molecular; Molecular Conformation; Nanomedicine; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2015 |
Pdots, a new type of nanoparticle, bind to mTHPC via their lipid modified surface and exhibit very high FRET efficiency between the core and the sensitizer.
Topics: Fluorescence Resonance Energy Transfer; Lipids; Mesoporphyrins; Molecular Structure; Nanoparticles; Particle Size; Photosensitizing Agents; Singlet Oxygen; Surface Properties; Time Factors | 2015 |
PEG-Phospholipids Coated Quantum Rods as Amplifiers of the Photosensitization Process by FRET.
Topics: Fluorescence; Fluorescence Resonance Energy Transfer; Kinetics; Mesoporphyrins; Nanocomposites; Phospholipids; Photosensitizing Agents; Polyethylene Glycols; Quantum Dots; Singlet Oxygen | 2015 |
Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Cell Survival; Endothelial Cells; Female; Light; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Nude; Micelles; Photochemotherapy; Photosensitizing Agents; Polyesters; RAW 264.7 Cells; Singlet Oxygen; Tissue Distribution | 2017 |
In vivo singlet molecular oxygen measurements: Sensitive to changes in oxygen saturation during PDT.
Topics: Animals; Chick Embryo; Lasers, Dye; Lasers, Solid-State; Mesoporphyrins; Oxygen; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2018 |